Refractory pure red-cell aplasia associated with B chronic lymphocytic leukemia successfully treated by fludarabine.
Sandra
S
S
Real
E
E
Pastor
E
E
Grau
E
E
D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007275:Injections, Intravenous; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D008297:Male; D008875:Middle Aged; D012010:Red-Cell Aplasia, Pure / Q000150:complications / Q000188:drug therapy*; D014740:Vidarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D007166:Immunosuppressive Agents; D014740:Vidarabine; C024352:fludarabine